Increased expression of herpesvirus entry mediator in 1,25-dihydroxyvitamin D3-treated mouse bone marrow-derived dendritic cells promotes the generation of CD4+CD25+Foxp3+ regulatory T cells

Molecular Medicine Reports

Volumn 9, Issue 3, 2014, Pages 813-818

  Huang, Yi ^a   Zhao, Yan ^b   Ran, Xuemei ^b   Wang, Changzheng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

1,25 dihydroxyvitamin D3; Bone marrow derived dendritic cells; Herpesvirus entry mediator; Regulatory T cell

Indexed keywords

ANIMALS; ANTIGENS, CD4; BONE MARROW CELLS; CALCITRIOL; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DOWN-REGULATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HERPESVIRIDAE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OVALBUMIN; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; T-LYMPHOCYTES, REGULATORY; UP-REGULATION; VITAMINS;

EID: 84893840264     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1874     Document Type: Article

References (36)

1. Casteels K, Bouillon R, Waer M and Mathieu C: Immunomodulatory effects of 1,25-dihydroxyvitamin D3. Curr Opin Nephrol Hypertens 4: 313-318, 1995.
2. Carlberg C: Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results Cancer Res 164: 29-42, 2003.
3. Griffin MD, Xing N and Kumar R: Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr 23: 117-145, 2003.
4. Mathieu C and Adorini L: The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents. Trends Mol Med 8: 174-179, 2002.
5. Adorini L: Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol 2: 1017-1028, 2002.
6. Adorini L: 1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation. Curr Opin Investig Drugs 3: 1458-1463, 2002.
7. Deluca HF and Cantorna MT: Vitamin D: its role and uses in immunology. FASEB J 15: 2579-2585, 2001.
8. Penna G and Adorini L: 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164: 2405-2411, 2000.
9. Piemonti L, Monti P, Sironi M, et al: Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 164: 4443-4451, 2000.
10. Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ and Kumar R: Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun 270: 701-708, 2000.
11. van Halteren AG, van Etten E, de Jong EC, Bouillon R, Roep BO and Mathieu C: Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3). Diabetes 51: 2119-2125, 2002.
12. Gauzzi MC, Purificato C, Donato K, et al: Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis. J Immunol 174: 270-276, 2005.
13. Dai H, Zhu H, Lei P, et al: Programmed death-1 signaling is essential for the skin allograft protection by alternatively activated dendritic cell infusion in mice. Transplantation 88: 864-873, 2009.
14. Wang L, Pino-Lagos K, de Vries VC, Guleria I, Sayegh MH and Noelle RJ: Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells. Proc Natl Acad Sci USA 105: 9331-9336, 2008.
15. Chen C, Qu QX, Huang JA, et al: Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells. Immunobiology 212: 159-165, 2007.
16. Kwon BS, Tan KB, Ni J, et al: A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem 272: 14272-14276, 1997.
17. Morel Y, Schiano de Colella JM, Harrop J, et al: Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J Immunol 165: 4397-4404, 2000.
18. Jung HW, La SJ, Kim JY, et al: High levels of soluble herpes virus entry mediator in sera of patients with allergic and autoimmune diseases. Exp Mol Med 35: 501-508, 2003.
19. Wang Y, Subudhi SK, Anders RA, et al: The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J Clin Invest 115: 711-717, 2005.
20. Sedy JR, Gavrieli M, Potter KG, et al: B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 6: 90-98, 2005.
21. Cai G, Wang H, Qin Q, et al: Amelioration of myocarditis by HVEM-overexpressing dendritic cells through induction of IL-10-producing cells. Cardiovasc Res 84: 425-433, 2009.
22. Zhang M, Tang H, Guo Z, et al: Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat Immunol 5: 1124-1133, 2004.
23. Latchman Y, Wood CR, Chernova T, et al: PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2: 261-268, 2001.
24. Freeman GJ, Long AJ, Iwai Y, et al: Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192: 1027-1034, 2000.
25. Kaliński P, Hilkens CM, Wierenga EA and Kapsenberg ML: T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunology Today 20: 561-567, 1999.
26. Lutz MB and Schuler G: Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 23: 445-449, 2002.
27. Anderson AE, Swan DJ, Sayers BL, et al: LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells. J Leukoc Biol 85: 243-250, 2009.
28. Alroy I, Towers TL and Freedman LP: Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15: 5789-5799, 1995.
29. Wölfle SJ, Strebovsky J, Bartz H, et al: PD-L1 expression on tolerogenic APCs is controlled by STAT-3. Eur J Immunol 41: 413-424, 2011.
30. Unger WW, Laban S, Kleijwegt FS, van der Slik AR and Roep BO: Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur J Immunol 39: 3147-3159, 2009.
31. Kuipers H, Muskens F, Willart M, et al: Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Eur J Immunol 36: 2472-2482, 2006.
32. Sadeghi K, Wessner B, Laggner U, et al: Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 36: 361-370, 2006.
33. Hewison M, Freeman L, Hughes SV, et al: Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 170: 5382-5390, 2003.
34. Dong X, Craig T, Xing N, et al: Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function. J Biol Chem 278: 49378-49385, 2003.
35. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ and Kumar R: Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 98: 6800-6805, 2001.
36. Szeles L, Keresztes G, Töröcsik D, et al: 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J Immunol 182: 2074-2083, 2009.